Curis Inc (CRIS) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.11
• Market Cap: $14.79M
• EPS: $-3.30
• 52-Week High: $3.18
• 52-Week Low: $0.77

Market Sentiment

Curis Inc currently has a Neutral sentiment score of 0.13.

About Curis Inc

Curis, Inc. (Ticker: CRIS) is a biotechnology company based in Lexington, Massachusetts, committed to developing targeted therapies to address significant unmet medical needs in oncology. Through its innovative proprietary platforms, Curis focuses on advancing novel drug candidates aimed at treating various cancers, thereby enhancing patient outcomes within this critical therapeutic area. With a strategic emphasis on research and development, Curis is poised to play a pivotal role in the futu...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Curis Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CRIS pay dividends?

Curis Inc (CRIS) does not currently pay a regular dividend.

What is CRIS's market cap?

Curis Inc (CRIS) has a market capitalization of $14.79M with a current stock price of $1.11.